Novel 15-Lipoxygenase-1 Inhibitor Protects Macrophages from Lipopolysaccharide-Induced Cytotoxicity. 2019

Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker

Various mechanisms for regulated cell death include the formation of oxidative mediators such as lipid peroxides and nitric oxide (NO). In this respect, 15-lipoxygenase-1 (15-LOX-1) is a key enzyme that catalyzes the formation of lipid peroxides. The actions of these peroxides are interconnected with nuclear factor-κB signaling and NO production. Inhibition of 15-LOX-1 holds promise to interfere with regulated cell death in inflammatory conditions. In this study, a novel potent 15-LOX-1 inhibitor, 9c (i472), was developed and structure-activity relationships were explored. In vitro, this inhibitor protected cells from lipopolysaccharide-induced cell death, inhibiting NO formation and lipid peroxidation. Thus, we provide a novel 15-LOX-1 inhibitor that inhibits cellular NO production and lipid peroxidation, which set the stage for further exploration of these mechanisms.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D000067996 RAW 264.7 Cells A transformed macrophage cell line isolated from ASCITES of mice infected with ABELSON MURINE LEUKEMIA VIRUS. RAW 264.7 Cell Line,264.7 Cell, RAW,264.7 Cells, RAW,Cell, RAW 264.7,Cells, RAW 264.7,RAW 264.7 Cell
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001093 Arachidonate 15-Lipoxygenase An enzyme that catalyzes the oxidation of arachidonic acid to yield 15-hydroperoxyarachidonate (15-HPETE) which is rapidly converted to 15-hydroxy-5,8,11,13-eicosatetraenoate (15-HETE). The 15-hydroperoxides are preferentially formed in NEUTROPHILS and LYMPHOCYTES. 15-Lipoxygenase,Arachidonic Acid 15-Lipoxygenase,15 Lipoxygenase,15-Lipoxygenase, Arachidonate,15-Lipoxygenase, Arachidonic Acid,Arachidonate 15 Lipoxygenase,Arachidonic Acid 15 Lipoxygenase
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015227 Lipid Peroxidation Peroxidase catalyzed oxidation of lipids using hydrogen peroxide as an electron acceptor. Lipid Peroxidations,Peroxidation, Lipid,Peroxidations, Lipid

Related Publications

Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
February 2003, Carcinogenesis,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
September 2009, Toxicology in vitro : an international journal published in association with BIBRA,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
June 2005, Journal of lipid research,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
September 2004, Molecular and cellular biology,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
January 1998, Life sciences,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
October 2001, Stroke,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
December 2005, Indian journal of experimental biology,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
February 2014, Free radical biology & medicine,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
July 2014, Molecular and cellular endocrinology,
Hao Guo, and Iris C Verhoek, and Gerian G H Prins, and Ramon van der Vlag, and Petra E van der Wouden, and Ronald van Merkerk, and Wim J Quax, and Peter Olinga, and Anna K H Hirsch, and Frank J Dekker
December 2018, Natural product research,
Copied contents to your clipboard!